» Articles » PMID: 29615011

Soluble Expression of an Amebic Cysteine Protease in the Cytoplasm of Escherichia Coli SHuffle Express Cells and Purification of Active Enzyme

Overview
Journal BMC Biotechnol
Publisher Biomed Central
Specialty Biotechnology
Date 2018 Apr 5
PMID 29615011
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recombinant production of amebic cysteine proteases using Escherichia coli cells as the bacterial system has become a challenging effort, with protein insolubility being the most common issue. Since many of these enzymes need a native conformation stabilized by disulfide bonds, an elaborate process of oxidative folding is usually demanded to get a functional protein. The cytoplasm of E. coli SHuffle Express cells owns an enhanced ability to properly fold proteins with disulfide bonds. Because of this cellular feature, it was possible to assume that this strain represents a reliable expression system and worthwhile been considered as an efficient bacterial host for the recombinant production of amebic cysteine proteases.

Results: Using E. coli SHuffle Express cells as the bacterial system, we efficiently produce soluble recombinant EhCP1protein. Enzymatic and inhibition analyses revealed that it exhibits proper catalytic abilities, proceeds effectively over the substrate (following an apparent Michaelis-Menten kinetics), and displays a typical inhibition profile.

Conclusions: We report the first feasibility study of the recombinant production of amebic cysteine proteases using E. coli SHuffle Express as the bacterial host. We present a simple protocol for the recombinant expression and purification of fully soluble and active EhCP1 enzyme. We confirm the suitability of recombinant EhCP1 as a therapeutic target. We propose an approachable bacterial system for the recombinant production of amebic proteins, particularly for those with a need for proper oxidative folding.

Citing Articles

Anti-HER2 scFv Expression in Escherichia coli SHuffleT7 Express Cells: Effects on Solubility and Biological Activity.

Ahmadzadeh M, Farshdari F, Nematollahi L, Behdani M, Mohit E Mol Biotechnol. 2019; 62(1):18-30.

PMID: 31691197 DOI: 10.1007/s12033-019-00221-2.


Purification and biochemical characterization of a novel thermostable protease from the oyster mushroom Pleurotus sajor-caju strain CTM10057 with industrial interest.

Omrane Benmrad M, Mechri S, Jaouadi N, Ben Elhoul M, Rekik H, Sayadi S BMC Biotechnol. 2019; 19(1):43.

PMID: 31262286 PMC: 6604391. DOI: 10.1186/s12896-019-0536-4.

References
1.
Schrader E, Harstad K, Matouschek A . Targeting proteins for degradation. Nat Chem Biol. 2009; 5(11):815-22. PMC: 4228941. DOI: 10.1038/nchembio.250. View

2.
Rub A, Arish M, Husain S, Ahmed N, Akhter Y . Host-lipidome as a potential target of protozoan parasites. Microbes Infect. 2013; 15(10-11):649-60. DOI: 10.1016/j.micinf.2013.06.006. View

3.
Lobstein J, Emrich C, Jeans C, Faulkner M, Riggs P, Berkmen M . SHuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulfide bonded proteins in its cytoplasm. Microb Cell Fact. 2012; 11:56. PMC: 3526497. DOI: 10.1186/1475-2859-11-56. View

4.
Tillack M, Biller L, Irmer H, Freitas M, Gomes M, Tannich E . The Entamoeba histolytica genome: primary structure and expression of proteolytic enzymes. BMC Genomics. 2007; 8:170. PMC: 1913524. DOI: 10.1186/1471-2164-8-170. View

5.
Di Genova B, Tonelli R . Infection Strategies of Intestinal Parasite Pathogens and Host Cell Responses. Front Microbiol. 2016; 7:256. PMC: 4776161. DOI: 10.3389/fmicb.2016.00256. View